Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference
Nautilus Biotechnology (NASDAQ: NAUT) will participate in the Investor Summit Group Virtual Conference.
Rhea-AI Summary
Nautilus Biotechnology (NASDAQ: NAUT) will participate in the Investor Summit Group Virtual Conference. Management is scheduled to present on Wednesday, March 25, 2026 at 10:00 a.m. PT / 1:00 p.m. ET. Live and archived webcasts will be available in the Investors section of the company website.
Investors can access the webcast at www.nautilus.bio.
Positive
- None.
Negative
- None.
Details
News Market Reaction – NAUT
In the Mar 24 session, NAUT gained 9.12%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Conference date
- March 25, 2026
- Investor Summit Group Virtual Conference presentation date
- Presentation time PT
- 10:00 a.m. Pacific Time
- Scheduled Nautilus management presentation slot
- Presentation time ET
- 1:00 p.m. Eastern Time
- Scheduled Nautilus management presentation slot
Historical Context
-
Baylor College of Medicine named first Early Access customer for Voyager platform.
-
Appointment of proteomics commercial leader as VP of Sales for Voyager launch.
-
Q4 and FY2025 results with significant operating expenses and net loss disclosed.
-
Voyager platform unveiled with high-throughput Iterative Mapping and Tau assay data.
-
Announcement of participation in TD Cowen health care conference with fireside chat.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
single-molecule protein analysis platform medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
SEATTLE, March 24, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the Investor Summit Group Virtual Conference.
Nautilus’ management is scheduled to present on Wednesday, March 25, 2026, at 10:00 a.m. Pacific Time / 1:00 p.m. Eastern Time. Interested parties may access live and archived webcasts of the presentations on the “Investors” section of the company website at: www.nautilus.bio.
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.
Media Contact
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.